Content Services
- Technical Writing
- Training & eLearning
- Financial Reports
- Digital Marketing
- SEO & Content Optimization
Translation Services
- Video Localization
- Software Localization
- Website Localization
- Translation for Regulated Companies
- Interpretation
- Instant Interpreter
- Live Events
- Language Quality Services
Testing Services
- Functional QA & Testing
- Compatibility Testing
- Interoperability Testing
- Performance Testing
- Accessibility Testing
- UX/CX Testing
Solutions
- Translation Service Models
- Machine Translation
- Smart Onboarding™
- Aurora AI Studio™
Our Knowledge Hubs
- Positive Patient Outcomes
- Modern Clinical Trial Solutions
- Future of Localization
- Innovation to Immunity
- COVID-19 Resource Center
- Disruption Series
- Patient Engagement
- Lionbridge Insights
Life Sciences
- Pharmaceutical
- Clinical
- Regulatory
- Post-Approval
- Corporate
- Medical Devices
- Validation and Clinical
- Regulatory
- Post-Authorization
- Corporate
Banking & Finance
Retail
Luxury
E-Commerce
Games
Automotive
Consumer Packaged Goods
Technology
Industrial Manufacturing
Legal Services
Travel & Hospitality
SELECT LANGUAGE:
Clinical trials rely heavily on Clinical Outcome Assessments (COAs) to receive regulatory approval. But with so many variables to juggle in choosing the right COA, one variable is often overlooked: translation.
In this new whitepaper, we’ll explore key translation challenges related to COAs and trial planning and design. We’ll also examine the importance linguistic validation for patients, and the fast-rising trend of digitizing COAs with Electronic Clinical Outcome Assessments (eCOAs).
Translation is an integral part of the COA process. Making sure those translations are accurate is as challenging as it is important. Every nuance matters. Multi-lingual clinical trials need to ensure consistency in their language for proper communication with patients as well as for compliance with regulatory standards. By partnering with a company experienced and in healthcare translation, organizations conducting clinical trials can improve COA performance and ultimately facilitate quality data collection and more precise clinical trial conclusions.